This event will feature two talks focusing on the cutting-edge use of digital PCR (dPCR) for research, exploring CAR-T cell monitoring in clinical research phases and high-throughput adeno-associated ...

Industry’s First 6-Color Digital PCR System Answers Market Needs for Higher Performance and Multiplexing Technology BOSTON & PARIS--(BUSINESS WIRE)--Stilla Technologies, the multiplex digital PCR ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ...

Even standard polymerase chain reaction (PCR) technology should, in principle, boost weak mutant signals so that they may emerge from all the genomic noise emitted by wild-type sequences. Yet standard ...

This GEN eBook examines how ddPCR technology is applied in practice through case studies highlighting its analytical strengths over traditional qPCR.

Digital PCR (dPCR) is a powerful technology for detecting and quantifying nucleic acids. In dPCR, nucleic acids within a sample are randomly distributed into numerous small-volume micro-reactions and ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, recently ...

Digital PCR is a specialized tool for nucleic acid quantification, which has applications in many research areas including those in microbiology and virology research. Leveraging optical multiplexing, ...

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...

Growing Adoption of Liquid Biopsy Technologies, Infectious Disease Surveillance, and AI-Powered Diagnostic Platforms Accelerate Global Digital PCR Market Expansion.Austin, United States, March 04, ...

FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 ...

Joining hands in fighting the global pandemic we are facing, we have developed, in collaboration with our Chinese partner ApexBio, a highly sensitive COVID-19 detection kit using Crystal Digital PCR.